9-[4-(DIPHOSPHORYLOXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-ADENINE
Compound with spectra: 1 NMR
![9-[4-(DIPHOSPHORYLOXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-ADENINE](/api/compound/JJroOQoXumF.png?ph=true&h=300&w=458 "9-[4-(DIPHOSPHORYLOXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-ADENINE")
| SpectraBase Compound ID | JJroOQoXumF |
|---|---|
| InChI | InChI=1S/C11H16N5O10P3/c12-10-9-11(14-4-13-10)16(5-15-9)7-1-2-8(3-7)24-6-27(17,18)25-29(22,23)26-28(19,20)21/h1-2,4-5,7-8H,3,6H2,(H,17,18)(H,22,23)(H2,12,13,14)(H2,19,20,21)/t7-,8+/m0/s1 |
| InChIKey | VUGGRZMGKXPUEU-JGVFFNPUSA-N |
| Mol Weight | 471.2 g/mol |
| Molecular Formula | C11H16N5O10P3 |
| Exact Mass | 471.011003 g/mol |
| Enantiomer InChIKey | VUGGRZMGKXPUEU-SFYZADRCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
P,P'-BIS-[[4-(ADENINE-9-YL)-CYCLOPENT-2-ENYL]-OXYMETHYLPHOSPHONYL]-PHOSPHATE
(1R,4S)-N-(6)-BENZOYL-9-(4-HYDROXY-2-CYClOPENTAN-1-YL)-9H-ADENINE
[(3R,5S)-3-(6-aminopurin-9-yl)-5-[(dimethyl-thexyl-silyl)oxymethyl]-1-cyclopentenyl]methanol
9-[(1'.beta.,3'a.alpha.,4'.beta.)-4'-(Dihydroxyphosphorylmethoxy)-3'-hydroxycyclopentyl}adenine 3',4'-cyclic acid ester
3',4'-CYCLIC-ESTER-OF-9-[(1'-BETA,3'-ALPHA,4'-BETA)-4'-(DIHYDROXYPHOSPHORYLMETHOXY)-3'-HYDROXYCYCLOPENTYL]-ADENINE
17;(1R,2S,4S)-4-(9H-ADENIN-9-YL)-2-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL-ACETATE;9-[(1S,3R,4S)-3-ACETOXY-4-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL]-9H-
(1'R,2'S,3'R,4'S)-1'-(6-Amino-9H-purin-9-yl)-4'-hydroxy[13C]methylcyclopentane-2',3'-diol [6'-[13C]Aristeromycin]
9-[trans-2',trans-3'-bis(benzyloxymethyl)cyclobut-1'-yl]adenine
2'-Deoxy-3'-O-butoylriboseadenine
2'-DEOXYNUCLEOSIDE-#3C
| Title | Journal or Book | Year |
|---|---|---|
| Carbocyclic Dinucleoside Polyphosphonates: Interaction with HIV Reverse Transcriptase and Antiviral Activity | Journal of Medicinal Chemistry | 2002 |